Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Anti-angiogenic treatment (sunitinib) for disseminated malignant haemangiopericytoma: a case study and review of the literature.

Delgado M, Pérez-Ruiz E, Alcalde J, Pérez D, Villatoro R, Rueda A.

Case Rep Oncol. 2011 Jan;4(1):55-9. doi: 10.1159/000324487. Epub 2011 Feb 5.

2.

Systemic treatment of neuroendocrine tumors with hepatic metastases.

Demirkan BH, Eriksson B.

Turk J Gastroenterol. 2012;23(5):427-37. Review.

3.

Haemangiopericytoma of the thyroid gland in combination with Hashimoto's disease.

Hansen T, Gaumann A, Ghalibafian M, Höferlin A, Heintz A, Kirkpatrick CJ.

Virchows Arch. 2004 Sep;445(3):315-9. Epub 2004 Jul 9.

PMID:
15243738
4.

Hepatic metastasis from a meningeal haemangiopericytoma.

Chakravarty BJ, Munn S, Lane MR.

Aust N Z J Med. 1991 Dec;21(6):884-5.

PMID:
1818550
5.

Novel anti-angiogenic therapies for malignant gliomas.

Norden AD, Drappatz J, Wen PY.

Lancet Neurol. 2008 Dec;7(12):1152-60. doi: 10.1016/S1474-4422(08)70260-6. Review.

PMID:
19007739
6.

Maxillary haemangiopericytoma: a case report.

Fatusi OA, Owotade FJ, Ojo OS.

West Afr J Med. 2004 Apr-Jun;23(2):180-4.

PMID:
15287302
7.

Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.

Kodera Y, Katanasaka Y, Kitamura Y, Tsuda H, Nishio K, Tamura T, Koizumi F.

Breast Cancer Res. 2011 Jun 21;13(3):R66. doi: 10.1186/bcr2903.

8.

Primary intracranial haemangiopericytoma: comparison of survival outcomes and metastatic potential in WHO grade II and III variants.

Damodaran O, Robbins P, Knuckey N, Bynevelt M, Wong G, Lee G.

J Clin Neurosci. 2014 Aug;21(8):1310-4. doi: 10.1016/j.jocn.2013.11.026. Epub 2014 Apr 13.

PMID:
24726230
9.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
10.

Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.

Croom KF, Perry CM.

Drugs. 2003;63(5):513-22; discussion 523-4. Review.

PMID:
12600228
11.

Haemangiopericytoma diagnosed from a metastasis 11years after surgery for "atypical meningioma".

Prakasha B, Jacob R, Dawson A, Joannides T.

Br J Radiol. 2001 Sep;74(885):856-8.

PMID:
11560836
12.

Sunitinib in the management of gastrointestinal stromal tumours (GISTs).

Hopkins TG, Marples M, Stark D.

Eur J Surg Oncol. 2008 Aug;34(8):844-50. Epub 2007 Dec 21. Review.

PMID:
18082353
13.

Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.

Lincoln DT, Singal PK, Al-Banaw A.

Anticancer Res. 2007 Nov-Dec;27(6B):4201-18. Erratum in: Anticancer Res. 2008 Mar-Apr;28(2b):1439.

14.

Rare case of hemangiopericytoma responds to sunitinib.

Mulamalla K, Truskinovsky AM, Dudek AZ.

Transl Res. 2008 Mar;151(3):129-33. doi: 10.1016/j.trsl.2007.12.007.

PMID:
18279811
15.

Contrasting effects of sunitinib within in vivo models of metastasis.

Welti JC, Powles T, Foo S, Gourlaouen M, Preece N, Foster J, Frentzas S, Bird D, Sharpe K, van Weverwijk A, Robertson D, Soffe J, Erler JT, Pili R, Springer CJ, Mather SJ, Reynolds AR.

Angiogenesis. 2012 Dec;15(4):623-41. doi: 10.1007/s10456-012-9291-z. Epub 2012 Jul 28.

16.

Primary and metastatic renal hemangiopericytoma.

Martín Martín S, Torrecilla Garcia-Ripoll JR, Trueba Arguiñarena FJ, Cortiñas Gonzalez JR.

Arch Esp Urol. 2014 Oct;67(8):704-7. English, Spanish.

PMID:
25306989
17.

Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.

Jimenez C, Cabanillas ME, Santarpia L, Jonasch E, Kyle KL, Lano EA, Matin SF, Nunez RF, Perrier ND, Phan A, Rich TA, Shah B, Williams MD, Waguespack SG.

J Clin Endocrinol Metab. 2009 Feb;94(2):386-91. doi: 10.1210/jc.2008-1972. Epub 2008 Nov 18.

PMID:
19017755
18.

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.

Kaley TJ, Wen P, Schiff D, Ligon K, Haidar S, Karimi S, Lassman AB, Nolan CP, DeAngelis LM, Gavrilovic I, Norden A, Drappatz J, Lee EQ, Purow B, Plotkin SR, Batchelor T, Abrey LE, Omuro A.

Neuro Oncol. 2015 Jan;17(1):116-21. doi: 10.1093/neuonc/nou148. Epub 2014 Aug 6.

19.

Haemangiopericytoma of the jaw.

Wushou A, Bai XF, Qi H, Xu Z, Zheng J, Li G.

J Craniomaxillofac Surg. 2014 Jul;42(5):689-94. doi: 10.1016/j.jcms.2013.09.016. Epub 2013 Oct 16.

PMID:
24252622
20.

Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.

Cripps C, Winquist E, Devries MC, Stys-Norman D, Gilbert R; Head and Neck Cancer Disease Site Group.

Curr Oncol. 2010 Jun;17(3):37-48.

Supplemental Content

Support Center